{"id":"https://openalex.org/W2906344255","doi":"https://doi.org/10.1093/neuonc/noy190","title":"A platform for efficient early evaluation of biomarker-associated therapies in newly diagnosed IDH wild-type, MGMT unmethylated glioblastoma","display_name":"A platform for efficient early evaluation of biomarker-associated therapies in newly diagnosed IDH wild-type, MGMT unmethylated glioblastoma","publication_year":2018,"publication_date":"2018-11-26","ids":{"openalex":"https://openalex.org/W2906344255","doi":"https://doi.org/10.1093/neuonc/noy190","mag":"2906344255","pmid":"https://pubmed.ncbi.nlm.nih.gov/30590835","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6303428"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noy190","doi":"https://doi.org/10.1093/neuonc/noy190","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noy190","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/21/1/6/27237331/noy190.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/21/1/6/27237331/noy190.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047608444","display_name":"Howard Colman","orcid":"https://orcid.org/0000-0002-4027-7317","observed_orcids":["https://orcid.org/0000-0002-4027-7317"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Howard Colman","raw_affiliation_strings":["Huntsman Cancer Institute and Department of Neurosurgery, University of Utah, Salt Lake City, Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute and Department of Neurosurgery, University of Utah, Salt Lake City, Utah","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5047608444"],"corresponding_institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":0.2781,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.57307061,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"21","issue":"1","first_page":"6","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/platform-trials","display_name":"platform trials","score":0.7139999866485596},{"id":"https://openalex.org/keywords/umbrella-trials","display_name":"umbrella trials","score":0.9049999713897705},{"id":"https://openalex.org/keywords/master-protocols","display_name":"master protocols","score":0.5519999861717224},{"id":"https://openalex.org/keywords/precision-medicine","display_name":"precision medicine","score":0.4020000100135803},{"id":"https://openalex.org/keywords/drug-development-efficiency","display_name":"drug development efficiency","score":0.5170000195503235},{"id":"https://openalex.org/keywords/adaptive-trial-design","display_name":"adaptive trial design","score":0.546999990940094},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.39500001072883606}],"concepts":[{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.8379061818122864},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.5948174595832825},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5043026208877563},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4327911138534546},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.42611169815063477},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3165510296821594},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.14660581946372986}],"mesh":[{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015254","descriptor_name":"DNA Modification Methylases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D025521","descriptor_name":"Tumor Suppressor Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045643","descriptor_name":"DNA Repair Enzymes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1093/neuonc/noy190","doi":"https://doi.org/10.1093/neuonc/noy190","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noy190","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/21/1/6/27237331/noy190.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5888768","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6303428","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6303428","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6303428","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"},{"id":"pmid:30590835","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30590835","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-oncology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/neuonc/noy190","doi":"https://doi.org/10.1093/neuonc/noy190","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noy190","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/21/1/6/27237331/noy190.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2906344255.pdf","grobid_xml":"https://content.openalex.org/works/W2906344255.grobid-xml"},"referenced_works_count":9,"referenced_works":["https://openalex.org/W2013816626","https://openalex.org/W2024484688","https://openalex.org/W2591064811","https://openalex.org/W2614376040","https://openalex.org/W2726405642","https://openalex.org/W2748703947","https://openalex.org/W2768158273","https://openalex.org/W2791377051","https://openalex.org/W2895627758"],"related_works":["https://openalex.org/W2614376040","https://openalex.org/W4413372408","https://openalex.org/W4200468578","https://openalex.org/W4403116114","https://openalex.org/W2124510896","https://openalex.org/W2990647095","https://openalex.org/W2768158273","https://openalex.org/W4403438500","https://openalex.org/W2026593847","https://openalex.org/W3012959001"],"abstract_inverted_index":{"See":[0],"the":[1,12,51,110,138,294,313,316,355,360,372,432,494,577,588,613,621,679,684,719,734,741,748,771,824,880,895,911,927,938,959,972],"article":[2],"by":[3,460,471,515,650],"Wick":[4,375],"et":[5,376],"al,":[6],"pp.":[7],"95\u2013107":[8],"The":[9,520,639,664],"impact":[10,779],"of":[11,26,40,43,116,155,167,175,185,193,288,315,328,341,393,415,479,488,500,623,656,686,721,762,892,907,926,931,941,980],"precision":[13],"medicine":[14],"era":[15],"has":[16,678,777],"unfortunately":[17],"not":[18,559,758],"resulted":[19],"in":[20,24,84,89,126,151,179,248,262,298,308,344,348,396,431,435,534,689,695,821,828,834,843,862,876,887,894,920,933,947,958],"a":[21,104,127,148,152,164,186,219,228,245,263,299,338,379,423,516,595,600,651,669,696,817,835,884,948],"substantial":[22],"improvement":[23],"survival":[25,528],"glioblastoma":[27],"(GBM)":[28],"patients.":[29,156],"Despite":[30],"extensive":[31,943],"molecular":[32,652],"knowledge":[33],"and":[34,86,113,130,199,203,213,235,418,450,462,466,549,569,585,644,660,691,715,753,767,813,923,967,976,987],"biomarker":[35,54,252,541,776,945],"subtyping":[36],"from":[37,438,747,799],"multiplatform":[38,445,944],"profiling":[39,459],"large":[41,114],"numbers":[42],"GBMs,":[44],"O6-methylguanine-DNA":[45],"methyltransferase":[46],"(MGMT)":[47],"promoter":[48],"methylation":[49,458],"is":[50,96,109,171,318,442,526,757,770,782],"only":[52,147,725],"clinical":[53,197,216,221],"used":[55,319,606],"to":[56,66,80,190,243,258,320,335,358,390,444,486,576,607,612,630,681,796,807,856,868,910,913],"(sometimes)":[57],"alter":[58],"treatment":[59,150,490,564,578,609,643,766,866,877],"for":[60,78,119,143,173,284,366,523,555,563,672,733,890,900,983],"newly":[61,401,901,985],"diagnosed":[62,402,902,986],"GBM.1":[63],"In":[64,136,188,371],"contrast":[65],"other":[67,93,100,955],"solid":[68,94],"tumors,":[69],"no":[70,809,873],"effective":[71],"biomarker-based":[72,417],"targeted":[73,342,589],"therapies":[74,178,261,343,688],"have":[75,201,239,537,706,815],"been":[76],"identified":[77],"GBM":[79,90,346,403,440,693,968],"date.":[81],"While":[82,157,700],"differences":[83,861],"biology":[85],"drug":[87,123,247,981],"penetration":[88],"compared":[91],"with":[92,163,404,422,581,592,637,784],"tumors":[95],"an":[97,412,506,538,774,803],"important":[98,855],"contributor,":[99],"factors":[101],"also":[102],"play":[103],"role.":[105],"One":[106],"complicating":[107],"factor":[108,787],"time":[111,622],"expense,":[112],"number":[115],"patients":[117,347,483,572,626,726,763],"required":[118],"traditional":[120],"phases":[121,144],"I/II/III":[122],"development":[124],"associations":[125],"relatively":[128],"rare":[129],"heterogeneous":[131],"disease":[132,265],"such":[133,964],"as":[134,280,282,668,965],"GBM.2":[135],"particular,":[137],"standard":[139,304],"randomized":[140,844],"2-arm":[141],"studies":[142,847,963],"II/III":[145],"evaluate":[146,244,259,337,683,858],"single":[149,153,220,246,697],"group":[154],"this":[158,703,829,916],"study":[159,207,273,301,317,333,410,676,839,863,882,888,952],"design":[160,297,677,825,889,917],"provides":[161],"results":[162,478,720],"high":[165],"degree":[166],"statistical":[168],"confidence,":[169],"it":[170,794],"inefficient":[172],"evaluation":[174,891,982],"many":[176],"potential":[177,680,708,772],"different":[180],"diseases":[181],"or":[182,251,266,277,286,305,326,473,497,611,634,781],"biomarker-defined":[183,345,690,749],"subtypes":[184],"disease.":[187],"order":[189],"address":[191,391],"some":[192,392,707],"these":[194,236,394],"challenges,":[195],"statisticians,":[196],"trialists,":[198],"regulators":[200],"developed":[202],"are":[204,469,484,627,728,831,848,872],"utilizing":[205],"novel":[206],"designs":[208,225,237,307,334],"that":[209,231,388,536,582,710,773,870],"can":[210,238,274,302],"improve":[211,354],"efficiency":[212],"answer":[214],"multiple":[215,233,249,260,598,687],"questions":[217],"within":[218,802],"trial.3\u20135":[222],"These":[223],"trial":[224,381,657],"often":[226],"include":[227,505,567],"master":[229],"protocol":[230,830],"governs":[232],"substudies,":[234,420],"various":[240],"aims,":[241],"including:":[242,447],"tumor":[250,481,596,653],"groups":[253],"(eg,":[254,268,788],"basket":[255],"study)":[256],"and/or":[257,324],"specific":[264,583],"subtype":[267],"umbrella":[269],"study).":[270],"A":[271],"platform":[272,300,409,698,951,956],"utilize":[275],"either":[276],"both":[278,416,984],"elements":[279],"well":[281],"allow":[283],"addition":[285],"deletion":[287],"substudies":[289,867,928],"depending":[290],"on":[291,477,493],"outcomes":[292],"during":[293,312],"trial.":[295,699],"Statistical":[296],"incorporate":[303],"Bayesian/adaptive":[306],"which":[309,436,970],"information":[310],"gleaned":[311],"operation":[314],"modify":[321],"patient":[322],"randomization":[323,761],"continuation":[325],"closure":[327],"individual":[329,722,775,804],"substudies.5,6":[330],"More":[331],"efficient":[332,507],"simultaneously":[336],"wide":[339],"variety":[340],"early":[349,896],"phase":[350,368,509,517,836,845,897,974,977],"II":[351,898,975],"could":[352,792],"significantly":[353],"field\u2019s":[356],"ability":[357],"prioritize":[359],"most":[361],"promising":[362],"drug-biomarker":[363],"target":[364,935,971],"combinations":[365],"confirmatory":[367],"III":[369,846,978],"testing.":[370],"current":[373],"issue,":[374],"al":[377],"describe":[378],"platform/umbrella":[380],"called":[382],"NCT":[383],"Neuro":[384],"Master":[385],"Match":[386],"(N2M2)":[387],"seeks":[389],"issues":[395],"isocitrate":[397],"dehydrogenase":[398],"(IDH)":[399],"wild-type,":[400],"unmethylated":[405],"MGMT":[406,812],"promoter.7":[407],"This":[408,675,790],"utilizes":[411],"interesting":[413],"combination":[414],"biomarker-independent":[419,692],"along":[421,591,636],"concurrent":[424],"temozolomide/radiation":[425],"control":[426,671,735,742],"group.":[427],"Patients":[428],"initially":[429],"enroll":[430],"discovery":[433],"portion,":[434],"tissue":[437],"initial":[439],"resection":[441],"subjected":[443],"profiling,":[446,482],"whole":[448],"exome":[449],"low":[451],"coverage":[452],"whole-genome":[453],"DNA":[454],"sequencing,":[455,457],"RNA":[456],"array,":[461],"gene":[463],"expression":[464],"arrays,":[465],"relevant":[467,616],"biomarkers":[468,557,810],"confirmed":[470],"immunohistochemistry":[472],"Sanger":[474],"sequencing.":[475],"Based":[476],"real-time":[480],"assigned":[485,575,629],"one":[487],"7":[489],"arms":[491],"based":[492],"presence":[495],"(match)":[496],"absence":[498],"(no-match)":[499],"predefined":[501],"biomarkers.":[502],"Individual":[503],"subtrials":[504,535,552],"(Bayesian)":[508],"I":[510],"component":[511],"(when":[512],"necessary)":[513],"followed":[514],"IIa":[518],"study.":[519],"primary":[521],"endpoint":[522],"each":[524],"substudy":[525],"progression-free":[527],"at":[529,620],"6":[530],"months.":[531],"Targeted":[532],"agents":[533],"associated":[539,556,580],"\u201cmatch\u201d":[540,750],"include:":[542],"asinercept,":[543,632],"alectinib,":[544],"idasanutlin,":[545],"atezolizumab,":[546,633],"vismodegib,":[547],"palbociclib,":[548],"temsirolimus.":[550],"Other":[551],"where":[553,840],"evidence":[554,930],"was":[558],"considered":[560],"strong":[561],"enough":[562],"assignment":[565,646],"\u201cno-match\u201d":[566],"asinercept":[568],"atezolizumab.":[570],"\u201cMatch\u201d":[571],"will":[573,586,604,647,711,730,905,953],"be":[574,605,648,731,853,906],"arm":[579,666],"biomarker,":[584],"receive":[587,631],"therapy":[590],"radiation.":[593,638],"When":[594],"harbors":[597],"\u201cmatches,\u201d":[599],"previously":[601],"described":[602],"algorithm":[603],"determine":[608],"assignment,8":[610],"best":[614],"performing":[615],"subtrial":[617,645],"(if":[618],"known":[619],"enrollment).":[624],"\u201cNo-match\u201d":[625],"randomly":[628],"temozolomide":[635,665],"final":[640],"decision":[641],"regarding":[642],"made":[649],"board":[654],"consisting":[655],"steering":[658],"committee":[659],"enrolling":[661],"site":[662],"members.":[663],"serves":[667],"contemporaneous":[670],"all":[673,765],"subtrials.":[674,723],"efficiently":[682],"efficacy":[685,932],"subpopulations":[694],"improving":[701],"efficiency,":[702],"approach":[704],"does":[705,744],"drawbacks":[709],"require":[712],"careful":[713],"analysis":[714],"consideration":[716],"when":[717],"evaluating":[718],"First,":[724],"who":[727],"\u201cno-matches\u201d":[729],"eligible":[732],"(temozolomide/external":[736],"beam":[737],"radiotherapy)":[738],"substudy,":[739],"so":[740],"population":[743],"potentially":[745],"differ":[746],"substudies.":[751],"Second":[752],"related,":[754],"since":[755],"there":[756,769,871],"true":[759],"balanced":[760],"among":[764],"control,":[768],"prognostic":[778,786,798,819],"itself,":[780],"correlated":[783],"another":[785],"age).":[789],"eventuality":[791],"make":[793],"hard":[795],"deconvolve":[797],"therapeutic":[800],"effects":[801],"substudy.":[805],"However,":[806],"date":[808],"beyond":[811],"IDH":[814],"shown":[816],"clear":[818],"effect":[820],"GBM.9":[822],"Thus":[823],"tradeoffs":[826],"utilized":[827],"appropriate,":[832],"particularly":[833],"IIa,":[837],"signal-finding":[838],"additional":[841],"confirmation":[842],"expected.":[849],"It":[850,904],"will,":[851],"however,":[852],"very":[854],"carefully":[857],"retrospectively":[859],"any":[860,925],"populations":[864],"between":[865],"ensure":[869],"unexpected":[874],"biases":[875],"assignment.":[878],"Overall,":[879],"N2M2":[881],"represents":[883],"significant":[885],"advance":[886],"drugs":[893],"space":[899],"GBM.":[903,989],"great":[908],"interest":[909],"field":[912],"see":[914],"how":[915],"plays":[918],"out":[919],"\u201creal":[921],"life,\u201d":[922],"whether":[924],"show":[929],"their":[934],"populations.":[936],"Furthermore,":[937],"practical":[939],"experience":[940],"using":[942],"data":[946],"large,":[949],"prospective":[950],"aid":[954],"efforts":[957],"field,":[960],"including":[961],"adaptive":[962],"INSIGhT9,10":[966],"AGILE,11":[969],"later":[973],"areas":[979],"recurrent":[988]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-01-01T00:00:00"}